問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
李潤川
下載
2021-07-01 - 2026-12-31
Condition/Disease
Test Drug
Participate Sites6Sites
Recruiting6Sites
2022-06-16 - 2026-06-30
Esophageal Squamous Cell Carcinoma (ESCC)
Keytruda injection RMK-4830MK-4280A Lenvima capsule R Lenvima capsule R Intaxel Injection R Irinotel Intravenous Infusion Concentrate
Participate Sites7Sites
Recruiting7Sites
2021-10-22 - 2023-07-14
Participate Sites5Sites
Recruiting5Sites
2022-05-02 - 2023-04-18
2022-04-01 - 2027-01-31
2022-03-25 - 2026-12-31
Participate Sites4Sites
Recruiting4Sites
2016-10-01 - 2025-12-31
2021-03-05 - 2026-12-31
Participate Sites8Sites
Recruiting8Sites
2022-06-01 - 2029-01-31
2020-12-15 - 2026-01-30
全部
